From the bench to the boardroom
News from the Buck and beyond
Scientist Spotlight: Birgit Schilling, PhD
Meet one of our most collaborative faculty members!
The first successful clinical trial for a new Alzheimer’s drug is making big news.
Buck professor Julie Andersen weighs in on the new Alzheimer’s drug lecanemab.
Ketone bodies: Likely good for aging—and maybe for the military too
Lead Translational Scientist Brianna Stubbs explains the Buck’s role in a major study
The Obesity Society says we need to change the way we talk about obesity
Buck professor Pankaj Kapahi agrees
A call for researchers in aging and environmental health sciences to join forces
A conversation with Buck professor Julie Andersen.
How Does Obesity Increase the Risk for Severe Covid-19 (and other infections, too)?
Spoiler alert: it’s inflammation
Buck researchers weigh in on why women are more likely to develop Alzheimer’s disease
A team from China has identified a reproductive hormone that may play a key role in boosting susceptibility for Alzheimer’s in women...
Healthy aging starts in our cells – and in the places where we live!
Healthy aging starts in our cells and in the communities where we live! In this blog we explore the Age-Friendly movement which is focused on making communities livable for people of all ages...
We’re excited about single-cell sequencing technology and think you should be too!
Professor Simon Melov is championing the use of single cell sequencing – calling it the biggest technological revolution in biology in the last 30 years...